$EW
Edwards Lifesciences Corp Stock $ew

$ew Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000109980017000028 Filed on July 28, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$841.8M	$759.3M
YoY Change	10.87%	23.1%
Cost Of Revenue	$211.1M	$202.5M
YoY Change	4.25%	27.68%
Gross Profit	$630.7M	$556.8M
YoY Change	13.27%	21.52%
Gross Profit Margin	74.92%	73.33%
Selling, General & Admin	$243.8M	$228.8M
YoY Change	6.56%	6.97%
% of Gross Profit	38.66%	41.09%
Research & Development	$134.4M	$112.5M
YoY Change	19.47%	15.38%
% of Gross Profit	21.31%	20.2%
Depreciation & Amortization	$18.90M	$18.00M
YoY Change	5.0%	7.14%
% of Gross Profit	3.0%	3.23%
Operating Expenses	$378.2M	$341.3M
YoY Change	10.81%	9.6%
Operating Profit	$241.0M	$215.5M
YoY Change	11.83%	46.8%
Interest Expense	$1.400M	$2.400M
YoY Change	-41.67%	-233.33%
% of Operating Profit	0.58%	1.11%
Other Income/Expense, Net	-$2.800M	-$100.0K
YoY Change	2700.0%
Pretax Income	$205.6M	$169.0M
YoY Change	21.66%	18.85%
Income Tax	$19.50M	$42.40M
% Of Pretax Income	9.48%	25.09%
Net Earnings	$186.1M	$126.6M
YoY Change	47.0%	12.33%
Net Earnings / Revenue	22.11%	16.67%
Basic Earnings Per Share	$0.88	$0.60
Diluted Earnings Per Share	$0.86	$0.58
COMMON SHARES
Basic Shares Outstanding	210.5M shares	212.2M shares
Diluted Shares Outstanding	215.7M shares	217.3M shares

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.132B	$1.061B
YoY Change	6.69%	-24.71%
Cash & Equivalents	$508.2M	$369.9M
Short-Term Investments	$623.6M	$690.9M
Other Short-Term Assets	$95.20M	$81.50M
YoY Change	16.81%	-27.49%
Inventory	$491.6M	$367.6M
Prepaid Expenses	$54.10M	$50.00M
Receivables	$510.7M	$425.8M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.283B	$1.985B
YoY Change	15.03%	-13.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$627.9M	$516.2M
YoY Change	21.64%	14.56%
Goodwill	$965.1M	$629.4M
YoY Change	53.34%	69.7%
Intangibles	$408.6M	$208.7M
YoY Change	95.78%	1004.23%
Long-Term Investments	$4.400M	$7.400M
YoY Change	-40.54%	4.23%
Other Assets	$116.8M	$126.4M
YoY Change	-7.59%	119.06%
Total Long-Term Assets	$2.855B	$2.066B
YoY Change	38.17%	57.58%
TOTAL ASSETS
Total Short-Term Assets	$2.283B	$1.985B
Total Long-Term Assets	$2.855B	$2.066B
Total Assets	$5.139B	$4.051B
YoY Change	26.83%	12.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$104.6M	$83.40M
YoY Change	25.42%	25.98%
Accrued Expenses	$368.8M	$343.5M
YoY Change	7.37%	51.19%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$562.5M	$478.2M
YoY Change	17.63%	7.41%
LONG-TERM LIABILITIES
Long-Term Debt	$1.017B	$602.5M
YoY Change	68.76%	0.37%
Other Long-Term Liabilities	$420.9M	$499.5M
YoY Change	-15.74%	82.17%
Total Long-Term Liabilities	$1.438B	$1.102B
YoY Change	30.46%	26.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$562.5M	$478.2M
Total Long-Term Liabilities	$1.438B	$1.102B
Total Liabilities	$2.199B	$1.580B
YoY Change	39.15%	19.74%
SHAREHOLDERS EQUITY
Retained Earnings	$4.332B	$3.606B
YoY Change	20.12%	17.17%
Common Stock	$1.512B	$1.261B
YoY Change	19.86%	15.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.746B	$2.218B
YoY Change	23.83%	27.69%
Treasury Stock Shares	33.60M shares	28.30M shares
Shareholders Equity	$2.940B	$2.471B
YoY Change
Total Liabilities & Shareholders Equity	$5.139B	$4.051B
YoY Change	26.83%	12.28%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	$186.1M	$126.6M
YoY Change	47.0%	12.33%
Depreciation, Depletion And Amortization	$18.90M	$18.00M
YoY Change	5.0%	7.14%
Cash From Operating Activities	$197.7M	$190.3M
YoY Change	3.89%	11.88%
INVESTING ACTIVITIES
Capital Expenditures	-$61.70M	-$78.20M
YoY Change	-21.1%	325.0%
Acquisitions
YoY Change
Other Investing Activities	-$576.5M	-$264.9M
YoY Change	117.63%	-957.28%
Cash From Investing Activities	-$638.2M	-$343.1M
YoY Change	86.01%	-2844.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	126.8M	31.70M
YoY Change	300.0%	-162.65%
NET CHANGE
Cash From Operating Activities	197.7M	190.3M
Cash From Investing Activities	-638.2M	-343.1M
Cash From Financing Activities	126.8M	31.70M
Net Change In Cash	-313.7M	-121.1M
YoY Change	159.04%	-191.74%
FREE CASH FLOW
Cash From Operating Activities	$197.7M	$190.3M
Capital Expenditures	-$61.70M	-$78.20M
Free Cash Flow	$259.4M	$268.5M
YoY Change	-3.39%	42.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001099800
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	211158030	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Edwards Lifesciences Corp
CY2016Q4	ew	Accrual For Property Payroll And Other Taxes Other Than Income Taxes Current AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent	35300000	USD
CY2017Q2	ew	Accrual For Property Payroll And Other Taxes Other Than Income Taxes Current AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent	35800000	USD
CY2016Q4	ew	Accrued Rebates AccruedRebates	36100000	USD
CY2017Q2	ew	Accrued Rebates AccruedRebates	39600000	USD
CY2016Q4	ew	Cumulative Income Loss From Equity Method Investments CumulativeIncomeLossFromEquityMethodInvestments	-3900000	USD
CY2017Q2	ew	Cumulative Income Loss From Equity Method Investments CumulativeIncomeLossFromEquityMethodInvestments	-4800000	USD
	ew	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitAmount	39500000	USD
CY2017Q2	ew	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitPercent	-0.142
	ew	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitPercent	-0.079
	ew	Loss Contingency Claims That If Settled Could Have A Material Adverse Impact Number LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber	1	lawsuit
CY2017Q2	ew	Number Of Acquisition Agreements NumberOfAcquisitionAgreements	2	agreement
	ew	Payments Related To Equity Forward Contract In Accelerated Share Repurchase Agreement PaymentsRelatedToEquityForwardContractInAcceleratedShareRepurchaseAgreement	35000000	USD
	ew	Payments Related To Equity Forward Contract In Accelerated Share Repurchase Agreement PaymentsRelatedToEquityForwardContractInAcceleratedShareRepurchaseAgreement	0	USD
	ew	Proceedsfrom Paymentsto Trading Securities Heldforinvestment ProceedsfromPaymentstoTradingSecuritiesHeldforinvestment	-5200000	USD
	ew	Proceedsfrom Paymentsto Trading Securities Heldforinvestment ProceedsfromPaymentstoTradingSecuritiesHeldforinvestment	-5800000	USD
CY2016Q4	ew	Reduction In Liabilities For Unrecognized Tax Benefits ReductionInLiabilitiesForUnrecognizedTaxBenefits	44900000	USD
CY2017Q2	ew	Reduction In Liabilities For Unrecognized Tax Benefits ReductionInLiabilitiesForUnrecognizedTaxBenefits	19400000	USD
CY2016Q2	ew	Research And Development Asset Acquired Other Than Through Business Combination Written Off And Related Expenses ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOffAndRelatedExpenses	34500000	USD
CY2016Q4	ew	Researchand Development Accruals ResearchandDevelopmentAccruals	40000000	USD
CY2017Q2	ew	Researchand Development Accruals ResearchandDevelopmentAccruals	37300000	USD
CY2016Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	414600000	USD
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	266500000	USD
CY2017Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	510700000	USD
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	532500000	USD
CY2017Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	562500000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	97100000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	104600000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5900000	USD
CY2017Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	65400000	USD
CY2016Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	12600000	USD
CY2017Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	12700000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-198400000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-157800000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1167800000	USD
CY2017Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1267000000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14300000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	28600000	USD
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15300000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	30500000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9000000	USD
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8500000	USD
CY2016Q4	us-gaap	Assets Assets	4510000000	USD
CY2017Q2	us-gaap	Assets Assets	5138500000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	2240000000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	2283400000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	400000	USD
CY2017Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2500000	USD
CY2017Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1400000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	603000000	USD
CY2017Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	647000000	USD
CY2016Q4	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax	100000	USD
CY2017Q2	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax	100000	USD
CY2016Q4	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	0	USD
CY2017Q2	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	0	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	117100000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	117000000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	425500000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	425200000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	104400000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	104400000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	600900000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	646600000	USD
CY2016Q4	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	100000	USD
CY2017Q2	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	100000	USD
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	USD
CY2016Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	400000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1000000	USD
CY2017Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3100000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	4200000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	31600000	USD
CY2017Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	198700000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	17200000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	16200000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	718400000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	369900000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	930100000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	508200000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-348500000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-421900000	USD
	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	3200000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	242600000	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	244700000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	211600000	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	211100000	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	242600000	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	244700000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	120500000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	273500000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	209800000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	456900000	USD
CY2016Q4	us-gaap	Cost Method Investments CostMethodInvestments	28200000	USD
CY2017Q2	us-gaap	Cost Method Investments CostMethodInvestments	12200000	USD
CY2016Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	202500000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	382800000	USD
CY2017Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	211100000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	426700000	USD
CY2017Q2	us-gaap	Costmethod Investments Other Than Temporary Impairment CostmethodInvestmentsOtherThanTemporaryImpairment	31200000	USD
CY2016Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	203800000	USD
CY2017Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	185200000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	33900000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	40000000	USD
CY2016Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3300000	USD
CY2017Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	15400000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.27
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.88
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.97
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.24
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.86
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.93
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-12700000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	3600000	USD
CY2016Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.251
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.235
CY2017Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.095
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.166
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	216100000	USD
CY2017Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	162600000	USD
CY2017Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	125700000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P33M
CY2016Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	9500000	USD
CY2017Q2	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	9200000	USD
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	5600000	USD
CY2017Q2	us-gaap	Equity Method Investments EquityMethodInvestments	4400000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	37200000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	37200000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-4200000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	162900000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	31600000	USD
CY2017Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	198700000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	1000000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	3700000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	626100000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	965100000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	556800000	USD
	us-gaap	Gross Profit GrossProfit	1073800000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	630700000	USD
	us-gaap	Gross Profit GrossProfit	1298600000	USD
CY2016Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	238300000	USD
CY2017Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	511800000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	0	USD
CY2017Q2	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	0	USD
CY2016Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	100000	USD
CY2017Q2	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	100000	USD
CY2017Q2	us-gaap	Held To Maturity Securities Debt Maturities Next Rolling Twelve Months Fair Value HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	506500000	USD
CY2017Q2	us-gaap	Held To Maturity Securities Debt Maturities Rolling Year Two Through Five Fair Value HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	0	USD
CY2017Q2	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	5200000	USD
CY2017Q2	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount	5200000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	238200000	USD
CY2017Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	511700000	USD
CY2017Q2	us-gaap	Heldtomaturity Securities Debt Maturities Next Rolling Twelve Months Amortized Cost HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost	506600000	USD
CY2017Q2	us-gaap	Heldtomaturity Securities Debt Maturities Rolling Year Two Through Five Amortized Cost HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost	0	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	169000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	352300000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	205600000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	499200000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	42400000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	82700000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19500000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	82900000	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	64700000	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	70500000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-12900000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-63800000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	60900000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-46000000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-200000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-43700000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	14700000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	72200000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-10400000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-6800000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	14000000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1300000	USD
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5100000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5000000	shares
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5200000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5300000	shares
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	204800000	USD
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	408600000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	2400000	USD
	us-gaap	Interest Expense InterestExpense	4800000	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	1400000	USD
	us-gaap	Interest Expense InterestExpense	3800000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	233600000	USD
CY2017Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	290000000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	396600000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	491600000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	60600000	USD
CY2017Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	79200000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	102400000	USD
CY2017Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	122400000	USD
CY2016Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	33900000	USD
CY2017Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	16700000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4510000000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5138500000	USD
CY2016Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	7800000	USD
CY2017Q2	us-gaap	Litigation Reserve Current LitigationReserveCurrent	8300000	USD
CY2016Q2	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	9100000	USD
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	21300000	USD
CY2017Q2	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	7700000	USD
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	17900000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	822300000	USD
CY2017Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1016800000	USD
CY2016Q4	us-gaap	Long Term Investments LongTermInvestments	532100000	USD
CY2017Q2	us-gaap	Long Term Investments LongTermInvestments	551500000	USD
	us-gaap	Maximum Length Of Time Foreign Currency Cash Flow Hedge MaximumLengthOfTimeForeignCurrencyCashFlowHedge	P13M
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-337400000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-264500000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-295800000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-487000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	297400000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	326000000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	126600000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	269600000	USD
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	186100000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	416300000	USD
CY2016Q4	us-gaap	Noncurrent Assets NoncurrentAssets	700000000	USD
CY2017Q2	us-gaap	Noncurrent Assets NoncurrentAssets	741000000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	78300000	USD
CY2017Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	80800000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	111800000	USD
CY2017Q2	us-gaap	Other Assets Current OtherAssetsCurrent	95200000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	123200000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	116800000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	26000000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-1200000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-20800000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-12300000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-18600000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-6700000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	20900000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	37200000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	60900000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6100000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3900000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	23700000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	40600000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-600000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-100000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-100000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-300000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4100000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2600000	USD
CY2016Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	64200000	USD
CY2017Q2	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	79400000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	504600000	USD
CY2017Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	420900000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3800000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-6900000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-100000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-100000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	380700000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	511200000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	174800000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	332300000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	84800000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	454500000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	505600000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	41100000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	6400000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-300000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-800000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-18700000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1500000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	3200000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1600000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3500000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5800000	USD
CY2016Q2	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	34500000	USD
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	34500000	USD
CY2017Q2	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	31200000	USD
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	31200000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	31000000	USD
	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	2000000	USD
	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	-300000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-4500000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	64800000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	73900000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	45900000	USD
CY2017Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	54100000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	15900000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	985400000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-100000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	800000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	94800000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	289400000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	347300000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	232000000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	44600000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	68700000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	580000000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	627900000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	4100000	USD
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	19300000	USD
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	808200000	USD
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	34500000	USD
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	5700000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	112500000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	214300000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	134400000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	263100000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3906300000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4331900000	USD
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	759300000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1456600000	USD
CY2017Q2	us-gaap	Sales Revenue Net SalesRevenueNet	841800000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1725300000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	228800000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	441500000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	243800000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	473400000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	28600000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	30500000	USD
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	341000000	USD
CY2017Q2	us-gaap	Short Term Investments ShortTermInvestments	623600000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	2619000000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	2939600000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	31000000	shares
CY2017Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	33600000	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2499300000	USD
CY2017Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2746200000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	245500000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	210800000	shares
CY2017Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	147100000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	200600000	USD
CY2017Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	127700000	USD
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	217300000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	217600000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	215700000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	216100000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	212200000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	212600000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	210500000	shares

Files In Submission

Name	View Source	Status
0001099800-17-000028-index-headers.html	Edgar Link	pending
0001099800-17-000028-index.html	Edgar Link	pending
0001099800-17-000028.txt	Edgar Link	pending
0001099800-17-000028-xbrl.zip	Edgar Link	pending
ew-20170630.xml	Edgar Link	completed
ew-20170630.xsd	Edgar Link	pending
ew-20170630_cal.xml	Edgar Link	unprocessable
ew-20170630_def.xml	Edgar Link	unprocessable
ew-20170630_lab.xml	Edgar Link	unprocessable
ew-20170630_pre.xml	Edgar Link	unprocessable
ew10-qq120_chartx55097a05.jpg	Edgar Link	pending
ew10-qq120_chartx56718a05.jpg	Edgar Link	pending
ew10-qq120_chartx58317a05.jpg	Edgar Link	pending
ew10-qq22017.htm	Edgar Link	pending
ew10-qq220_chartx39380a04.jpg	Edgar Link	pending
ew10-qq220_chartx39428a04.jpg	Edgar Link	pending
ew10-qq220_chartx40257a04.jpg	Edgar Link	pending
ew10-qq220_chartx40915a04.jpg	Edgar Link	pending
ew10-qq220_chartx40975a04.jpg	Edgar Link	pending
ew10-qq220_chartx43964a04.jpg	Edgar Link	pending
ew10-qq220_chartx45302a04.jpg	Edgar Link	pending
ew10-qq220_chartx46645a04.jpg	Edgar Link	pending
ex-10110xqq22017.htm	Edgar Link	pending
ex-10210xqq22017.htm	Edgar Link	pending
ex-31110xqq22017.htm	Edgar Link	pending
ex-31210xqq22017.htm	Edgar Link	pending
ex-3210xqq22017.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EW
Edwards Lifesciences Corp Stock $ew

2017 Q2 Form 10-Q Financial Statement

#000109980017000028 Filed on July 28, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EW Edwards Lifesciences Corp Stock $ew

2017 Q2 Form 10-Q Financial Statement

#000109980017000028 Filed on July 28, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EW
Edwards Lifesciences Corp Stock $ew